Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

FROM THE ANALYST'S COUCH

Immuno-oncology drug development goes global

Anna-Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA.

Search for this author in:

Anna-Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA.

Search for this author in:

Anna-Maria Kellen Clinical Accelerator, Cancer Research Institute, New York, NY, USA.
Contact

Search for this author in:

ORCiD: http://orcid.org/0000-0002-8285-5111

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Nature Reviews Drug Discovery 18, 899-900 (2019)

Updates & Corrections

  • Correction 22 November 2019: In the original version of Figure 3, the colours of the bars representing cell therapies and cancer vaccines were interchanged for some of the countries. The figure has been replaced to reflect the correct number of agents in both of these categories.

Supplementary Information

  1. Supplementary figures

Competing Financial Interests

The authors declare no competing interests.

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links